Retatrutide

Retatrutide GLP3

Retatrutide is a cutting-edge, multi-receptor peptide currently being studied for its powerful potential in metabolic regulation, fat reduction, and glucose control. Known as a triple agonist, Retatrutide acts on three key receptors — GLP-1, GIP, and glucagon — making it one of the most comprehensive peptides under research for supporting weight management and overall metabolic health.

Scientific Insight:
Unlike single-pathway peptides, Retatrutide targets multiple metabolic systems simultaneously. Retatrutide simultaneously targets three major metabolic receptors:

GLP-1 Receptors

Support appetite control, stable energy, and healthier blood-sugar responses.

GIP Receptors

Promote efficient nutrient use and help regulate food intake.

Glucagon Receptors (GCGR)

Encourage the body to burn stored energy and support fat-oxidation pathways.

Most peptides work through just one pathway.
RETA works through three, creating stronger, more comprehensive metabolic support

Potential Applications (for research use):

• Supports fat metabolism and weight management

• May improve glucose regulation and insulin sensitivity

• Promotes energy expenditure and lean mass retention

• Potential role in metabolic and cardiovascular health

Molecular Formula: C₂₁₉H₃₄₀N₆₂O₆₅
Molecular Weight: 4687.48 g/mol

Storage & Handling:
Store in a cool, dry place. Protect from light and moisture. Reconstituted peptide should be refrigerated and used within the recommended timeframe for optimal stability.

Disclaimer:
For laboratory research use only. Not for human consumption or therapeutic application.